A Novel Toxicity Scoring System Treating Toxicity Response as a Quasi-Continuous Variable in Phase I Clinical Trials

Contemporary Clinical Trials - Netherlands
doi 10.1016/j.cct.2010.05.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience

2010English

Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials

PLoS ONE
Multidisciplinary
2014English

A Trivariate Continual Reassessment Method for Phase I/Ii Trials of Toxicity, Efficacy, and Surrogate Efficacy

Statistics in Medicine
EpidemiologyStatisticsProbability
2012English

A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies

Oncologist
Cancer ResearchMedicineOncology
2020English

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/Ii Trials

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2009English

Patterns of Heavy Metals in a Continuous Toxicity Monitoring System Using Bioluminescent Bacteria

Journal of Korean Society of Environmental Engineers
2020English

A Dynamic Stopping Rule for Phase I Clinical Trials

Biometrical Letters
2018English

Validation of Prognostic Scoring and Assessment of Clinical Benefit for Patients With Bone Sarcomas Enrolled in Phase I Clinical Trials

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy